Avadel pharmaceuticals appoints dr. douglas williamson as chief medical officer

Dublin, ireland, feb. 14, 2022 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a company focused on transforming medicines to transform lives, today announced the appointment of douglas williamson, mbchb, as chief medical officer.

AVDL Ratings Summary

AVDL Quant Ranking